| Renee A Mcintosh, OD | |
|
11820 S State St, Ste. 200, Draper, UT 84020-7133 | |
| (801) 568-0200 | |
| (801) 563-0200 |
| Full Name | Renee A Mcintosh |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 25 Years |
| Location | 11820 S State St, Draper, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003057894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 47865699934 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hoopes Vision Correction Center Pc | 7618874231 | 9 |
News Archive
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
New scientific evidence on how feedback from the eye affects visual development may lead to more effective approaches to treating myopia (nearsightedness) in children, reports a paper in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papilloma virus (HPV) testing, could improve the screening rate among transgender men.
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
› Verified 6 days ago
| Provider Name | Hoopes Vision Correction Center Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982759122 PECOS PAC ID: 7618874231 Enrollment ID: O20031212000668 |
News Archive
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
New scientific evidence on how feedback from the eye affects visual development may lead to more effective approaches to treating myopia (nearsightedness) in children, reports a paper in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papilloma virus (HPV) testing, could improve the screening rate among transgender men.
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renee A Mcintosh, OD 11820 S State St, Ste. 200, Draper, UT 84020-7133 Ph: (801) 568-0200 | Renee A Mcintosh, OD 11820 S State St, Ste. 200, Draper, UT 84020-7133 Ph: (801) 568-0200 |
News Archive
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
New scientific evidence on how feedback from the eye affects visual development may lead to more effective approaches to treating myopia (nearsightedness) in children, reports a paper in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papilloma virus (HPV) testing, could improve the screening rate among transgender men.
In the future, even before the start of the treatment, physicians will be able to establish how patient's blood binds a given medicine and what doze should be applied in order to obtain the concentration in the body that would be optimal for the treatment. A new simple method of analysis of chemical reactions proceeding in solutions has been developed in the Institute of Physical Chemistry of the Polish Academy of Sciences.
Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.
› Verified 6 days ago
Hidden Valley Eye Care, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1147 Draper Pkwy, Ste A, Draper, UT 84020 Phone: 801-619-9555 Fax: 801-406-0444 | |
Mellor Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15037 Winged Bluff Ln, Draper, UT 84020 Phone: 801-867-9382 | |
Lumen Optical, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 261 W Data Dr, Draper, UT 84020 Phone: 801-316-5508 | |
Dr. Sherman H Peirce, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12357 S 450 E, Suite 2, Draper, UT 84020 Phone: 801-572-9804 Fax: 801-572-9805 | |
Hidden Valley Eye Care And Framed Optical Optometrist Medicare: Medicare Enrolled Practice Location: 1147 E Draper Pkwy, Draper, UT 84020 Phone: 801-916-9555 | |
South Valley Optical Optometrist Medicare: Medicare Enrolled Practice Location: 261 W. Data Dr., Draper, UT 84020 Phone: 801-316-5508 Fax: 801-316-7529 |